REVS – Columbia Research Enhanced Value ETF

Columbia Research Enhanced Value ETF (REVS) is a Large Value ETF, issued by Columbia Threadneedle, $186M in assets, 0.19% expense ratio.

Returns as of Oct 23, 2026: 1 week +0.6%, 1 year +14.6%.

Tracks rules-based index of Russell 1000 Value companies. Aims for stronger returns than broad U.S. large- and mid-cap value stocks.

Top holdings

• WFC – Wells Fargo & Company, 3.7%
• PG – Procter & Gamble Company, 3.4%
• XOM – Exxon Mobil Corp, 3.1%
• GOOGL – Alphabet Inc Class A, 2.9%
• CSCO – Cisco Systems Inc, 2.6%
• GOOG – Alphabet Inc Class C, 2.4%
• C – Citigroup Inc, 2.3%
• PFE – Pfizer Inc, 2.2%
• SPGI – S&P Global Inc, 2.2%
• SCHW – Charles Schwab Corp, 2.1%
• CVX – Chevron Corp, 1.8%
• UNP – Union Pacific Corporation, 1.6%
• CVS – CVS Health Corp, 1.5%
• CRM – Salesforce.com Inc, 1.5%
• BMY – Bristol-Myers Squibb Company, 1.4%
• AMD – Advanced Micro Devices Inc, 1.3%
• QCOM – Qualcomm Incorporated, 1.2%
• GD – General Dynamics Corporation, 1.2%
• USB – U.S. Bancorp, 1.1%
• TJX – The TJX Companies Inc, 1.1%
• CI – Cigna Corp, 1.1%
• NEM – Newmont Goldcorp Corp, 1.0%
• BK – The Bank of New York Mellon Corporation, 1.0%
• MO – Altria Group, 1.0%
• META – Meta Platforms Inc., 1.0%

Important ETFs